Global Needle Biopsy Market Key Insights Based on Product Type, End-use and Regional Demand

SDKI Inc. published a new report on the global needle biopsy market. This study includes the statistical and analytical approaches needed to grow the needle biopsy market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-91629

The needle biopsy market is estimated to reach US $ 872.39 million by 2030 from a market value of US $ 611.79 million in 2022 and is expected to grow at a CAGR of 5.20% during the 2022-2030 forecast period. increase.

Needle biopsy is a process used to collect cells from the body. Fine needle biopsy and core needle biopsy are two types of common needle biopsy. They are usually used to take samples from muscles, bones, and other parts of the body. In addition, needle biopsy is usually done to detect certain symptoms such as infections, inflammation, masses, and lumps. It is also considered an important approach for excluding or diagnosing breast cancer. A core needle biopsy is done on a lump that can be felt, a palpable mass, or a suspicious area that is seen after an imaging test or mammogram.

In addition, key players are focusing on strategies such as product launches, innovations and M & A to maintain themselves in fierce competition. Increasing prevalence of breast cancer and technological advances and developments in cancer-related research are key drivers of the growth of the needle biopsy market during the 2022-2030 forecast period. According to Our World in Data Organization, breast cancer is the most common form of cancer, with an estimated 17 million people suffering from breast cancer in 2017. In addition, about 2 million new cases worldwide were enrolled in breast cancer in 2018, according to sources. According to the American Cancer Society, breast cancer is the second leading cause of cancer-related death in women worldwide. Therefore, the need and usefulness of needle biopsy will increase and promote the growth of the needle biopsy market.

However, the high price of needle biopsy may hinder the growth of the needle biopsy market during the 2022-2030 forecast period.

Sample URL of the report
https://www.sdki.jp/sample-request-91629

Needle biopsy market segment

The needle biopsy market is divided by type (core needle biopsy, vacuum-assisted biopsy, image-guided biopsy), utility (disposable and reusable), application (tumor, infection, inflammation, etc.), and region. .. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Regional Overview of the Needle Biopsy Market

North American region is the world's leading region in terms of market share. This is due to the increased number of reported cancer cases, high per capita medical costs, and significant investment in research and development of effective alternative therapies. The region's dominance has also been witnessed due to favorable reimbursement scenarios and greater spending on medical care. Meanwhile, the Asia Pacific needle biopsy market is expected to show the highest growth rate / CAGR during the forecast period (2022-2030).

These regional segments are North America (US and Canada); Asia Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Singapore, Other Asia Pacific); Latin America (Brazil, Mexico, Argentina, etc.) Latin America); Middle East and Africa (Israel, GCC [Saudi Arabia, Arab Emirates, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, and other Middle East and Africa) and Europe (UK, Germany, France, Italy) , Spain, Hungary, Belgium, Netherlands, Luxemburg, NORDIC, Poland, Turkey, Russia and other Europe) and more.

Major key player in the needle biopsy market

Major key players in the needle biopsy market include Boston Scientific Corporation, Cook Medical, Carefusion Corporation, Hologic, Inc., Cardinal Health, Inc., Medax, CR Bard, Möller Medical Gmbh, Becton, Dickinson And Company, Hakko Co. Ltd. and so on. The survey includes a detailed competitive analysis of these major companies in the needle biopsy market, corporate profiles, recent developments, and key market strategies.

Details of the survey report
https://www.sdki.jp/press-details/global-needle-biopsy-market/210

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.